MedPath

Sagent Pharmaceuticals

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

133

FDA:133

Drug Approvals

BORTEZOMIB

Approval Date
May 5, 2025
FDA

Nafcillin

Approval Date
Apr 27, 2025
FDA

Melphalan Hydrochloride

Approval Date
Mar 25, 2024
FDA

ampicillin

Approval Date
Feb 14, 2024
FDA

Clindamycin

Approval Date
Feb 12, 2024
FDA

Clindamycin

Approval Date
Feb 12, 2024
FDA

cefazolin

Approval Date
Feb 11, 2024
FDA

Paclitaxel

Approval Date
Jan 20, 2024
FDA

Cisplatin

Approval Date
Jan 20, 2024
FDA

Piperacillin, Tazobactam

Approval Date
Jan 17, 2024
FDA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 14
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.